Continuum Clinical
Nariman Nasser has a diverse work experience spanning various roles in the pharmaceutical and clinical research industry. Starting in 2000, Nasser worked as a Project Coordinator at Caspian Consulting until 2004. In 2004, Nasser joined Biomarin as a Clinical Research Associate. Subsequently, Nasser worked at Genentech as a Project Coordinator/Manager in 2005.
Nasser then took on roles at the Immune Tolerance Network, starting as a Manager of Clinical Operations from 2005 to 2008, and later becoming the Associate Director of Clinical Operations from 2008 to 2010. From 2010 to 2013, Nasser worked at the UCSF Clinical & Translational Science Institute, first as a Director of Participant Recruitment Service and later as the Senior Director of Participant Recruitment & Study Management Services.
In 2013, Nasser founded Only For Good, an organization that is currently ongoing. Additionally, Nasser joined Roche in 2013 as a Digital Strategist until 2015. From 2015 to 2016, Nasser worked as the Global Head of Operational Innovation at Roche.
Since 2016, Nasser has been employed at Continuum Clinical. From 2016 to 2021, Nasser served as the Vice President of Global Site Solutions. In 2021, Nasser was promoted to Senior Vice President of Global Site Solutions. Then, in June 2022, Nasser took on the role of Executive Vice President of Product & Partnership Solutions, which is the most recent position held.
Nariman Nasser obtained a Bachelor of Science degree in Microbiology and Immunology from Arizona State University, completing the program from 1992 to 1996. Beyond this degree, Nariman has also received certification as a Certified Clinical Research Professional from the Society of Clinical Research Associates, although the specific month and year of obtaining this certification are not provided.
This person is not in any offices
Continuum Clinical
Continuum Clinical is a global clinical trial enrollment company, which has been providing fact-based patient recruitment solutions for 30 years. During this time, we have built successful and collaborative relationships with pharmaceutical and biotech companies around the world, including 16 of the top 20 global sponsors. This led Continuum Clinical to become the industry’s most trusted partner for clinical trial engagement, recruitment, and retention. We specialize in identifying and solving the known and unknown challenges that impact successful clinical trial enrollment – from protocol development through study completion. We use the industry’s most comprehensive range of professional services delivered by a multi-disciplinary team of subject matter experts in patient insights, communications, analytics, patient engagement and outreach, site support, advocacy, inclusion – all powered by a suite of technology products that generate actionable data that overcomes enrollment and awareness barriers. Our ContinuVue® platform incorporates multiple patient recruitment data streams, which provides actionable insights that enable us to meet and exceed sponsors’ enrollment goals. It consolidates data from multiple sources to help quickly identify program trends, eliminate uncertainties, and optimize enrollment strategies. With ContinuVue, sponsors can gain a complete, real-time picture of trial enrollment and study sites can easily manage and report on referral disposition. Headquartered in the United States, Continuum Clinical has over 120 employees in the United States and Europe, with an expanded network of resources worldwide.